Harriet Johansson

3.4k total citations
83 papers, 2.5k citations indexed

About

Harriet Johansson is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, Harriet Johansson has authored 83 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Genetics, 41 papers in Oncology and 31 papers in Molecular Biology. Recurrent topics in Harriet Johansson's work include Estrogen and related hormone effects (37 papers), Cancer Risks and Factors (28 papers) and Growth Hormone and Insulin-like Growth Factors (15 papers). Harriet Johansson is often cited by papers focused on Estrogen and related hormone effects (37 papers), Cancer Risks and Factors (28 papers) and Growth Hormone and Insulin-like Growth Factors (15 papers). Harriet Johansson collaborates with scholars based in Italy, United States and Norway. Harriet Johansson's co-authors include Andrea DeCensi, Sara Gandini, Bernardo Bonanni, Aliana Guerrieri‐Gonzaga, Sara Raimondi, Davide Serrano, Maria Teresa Sandri, Patrick Maisonneuve, Massimiliano Cazzaniga and Serena Mora and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Harriet Johansson

80 papers receiving 2.4k citations

Peers

Countries citing papers authored by Harriet Johansson

Since Specialization

Citations

This map shows the geographic impact of Harriet Johansson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harriet Johansson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harriet Johansson more than expected).

Fields of papers citing papers by Harriet Johansson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harriet Johansson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harriet Johansson. The network helps show where Harriet Johansson may publish in the future.

Co-authorship network of co-authors of Harriet Johansson

This figure shows the co-authorship network connecting the top 25 collaborators of Harriet Johansson. A scholar is included among the top collaborators of Harriet Johansson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harriet Johansson. Harriet Johansson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prognostic Value of PCSK9 Levels in Premenopausal Women at Risk of Breast Cancer—Evidence from a 17-Year Follow-Up Study 2024 ·Cancers ·Massimiliano Ruscica, Chiara Macchi, Sara Gandini, Debora Macis, Aliana Guerrieri‐Gonzaga, Valentina Aristarco, Davide Serrano, Matteo Lazzeroni, (unknown), Aurora Gaeta, Alberto Corsini, Marcella Gulisano, Harriet Johansson, Bernardo Bonanni	0
2	Effect of metformin and lifestyle intervention on adipokines and hormones in breast cancer survivors: a pooled analysis from two randomized controlled trials 2024 ·Breast Cancer Research and Treatment ·Harriet Johansson, Federica Bellerba, Debora Macis, (unknown), Aliana Guerrieri‐Gonzaga, Valentina Aristarco, Kristin Viste, Gunnar Mellgren, (unknown), (unknown), Augustin Scalbert, Dorothy D. Sears, Sara Gandini, Andrea DeCensi, Bernardo Bonanni	5
3	Vitamin D Supplementation and Adherence to World Cancer Research Fund (WCRF) Diet Recommendations for Colorectal Cancer Prevention: A Nested Prospective Cohort Study of a Phase II Randomized Trial 2023 ·Biomedicines ·Davide Serrano, Federica Bellerba, Harriet Johansson, Debora Macis, Valentina Aristarco, (unknown), Aliana Guerrieri‐Gonzaga, Cristina Trovato, Maria Giulia Zampino, Emanuela Omodeo Salè, Bernardo Bonanni, Sara Gandini, Patrizia Gnagnarella	3
4	Development of an HPLC-MS/MS Method for the Determination of Silybin in Human Plasma, Urine and Breast Tissue 2020 ·Molecules ·Matteo Lazzeroni, Giovanna Petrangolini, (unknown), (unknown), (unknown), (unknown), Debora Macis, Valentina Aristarco, Bernardo Bonanni, Paolo Morazzoni, Harriet Johansson, Antonella Riva	3
5	First-in-human pharmacokinetics of tamoxifen and its metabolites in the milk of a lactating mother: a case study 2020 ·ESMO Open ·Fedro A. Peccatori, Giovanni Codacci-Pisanelli, Gunnar Mellgren, Barbara Buonomo, (unknown), Ernst A. Lien, Ersilia Bifulco, Steinar Hustad, (unknown), Harriet Johansson, (unknown)	8
6	Prognostic impact of genetic variants of CYP19A1 and UGT2B17 in a randomized trial for endocrine-responsive postmenopausal breast cancer 2019 ·The Pharmacogenomics Journal ·Harriet Johansson, Valentina Aristarco, Sara Gandini, Jennifer Gjerde, Debora Macis, Aliana Guerrieri‐Gonzaga, Davide Serrano, Matteo Lazzeroni, (unknown), Clark Williard, Gunnar Mellgren, Andrea DeCensi, Bernardo Bonanni	9
7	A pooled analysis of CYP2D6 genotype in breast cancer prevention trials of low-dose tamoxifen 2016 ·Breast Cancer Research and Treatment ·Harriet Johansson, Sara Gandini, Davide Serrano, Jennifer Gjerde, (unknown), Debora Macis, Aliana Guerrieri‐Gonzaga, Valentina Aristarco, Gunnar Mellgren, Ernst A. Lien, Andrea DeCensi, Bernardo Bonanni	11
8	Telomere length and the risk of cutaneous melanoma and non-melanoma skin cancer: a review of the literature and meta-analysis 2015 ·Journal of Dermatological Science ·Saverio Caini, Sara Raimondi, Harriet Johansson, Vincenzo De Giorgi, Ines Zanna, Domenico Palli, Sara Gandini	34
9	Association of molecular subtypes with Ki-67 changes in untreated breast cancer patients undergoing pre-surgical trials 2013 ·Annals of Oncology ·Sara Gandini, Aliana Guerrieri‐Gonzaga, Giancarlo Pruneri, Davide Serrano, Marina Elena Cazzaniga, Matteo Lazzeroni, Paolo Veronesi, Harriet Johansson, Bernardo Bonanni, Giuseppe Viale, Andrea DeCensi	29
10	Dual Effect of Metformin on Breast Cancer Proliferation in a Randomized Presurgical Trial 2012 ·Journal of Clinical Oncology ·Bernardo Bonanni, Matteo Puntoni, Massimiliano Cazzaniga, Giancarlo Pruneri, Davide Serrano, Aliana Guerrieri‐Gonzaga, Alessandra Gennari, (unknown), Viviana Galimberti, Paolo Veronesi, Harriet Johansson, Valentina Aristarco, Fabio Bassi, Alberto Luini, Matteo Lazzeroni, Clara Varricchio, Giuseppe Viale, Paolo Bruzzi, Andrea DeCensi	195
11	Lapatinib Activity in Premalignant Lesions and HER-2–Positive Cancer of the Breast in a Randomized, Placebo-Controlled Presurgical Trial 2011 ·Cancer Prevention Research ·Andrea DeCensi, Matteo Puntoni, Giancarlo Pruneri, Aliana Guerrieri‐Gonzaga, Matteo Lazzeroni, Davide Serrano, Debora Macis, Harriet Johansson, (unknown), Alberto Luini, Paolo Veronesi, Viviana Galimberti, (unknown), Giuseppe Viale, Bernardo Bonanni	48
12	Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancer 2010 ·Annals of Oncology ·Andrea DeCensi, Aliana Guerrieri‐Gonzaga, Sara Gandini, Davide Serrano, Marina Elena Cazzaniga, Serena Mora, Harriet Johansson, Ernst A. Lien, Giancarlo Pruneri, Giuseppe Viale, Bernardo Bonanni	59
13	Efficacy of tamoxifen based on cytochrome P450 2D6, CYP2C19 and SULT1A1 genotype in the Italian Tamoxifen Prevention Trial 2010 ·The Pharmacogenomics Journal ·Davide Serrano, Matteo Lazzeroni, Carlo‐Federico Zambon, Debora Macis, Patrick Maisonneuve, Harriet Johansson, Aliana Guerrieri‐Gonzaga, Mario Plebani, Daniela Basso, Jennifer Gjerde, Gunnar Mellgren, Nicole Rotmensz, Andrea DeCensi, Bernardo Bonanni	52
14	Perioperative serum VEGF and extracellular domains of EGFR and HER2 in early breast cancer. 2009 ·PubMed ·Andrea Rocca, Giuseppe Cancello, Vincenzo Bagnardi, Maria Teresa Sandri, Rosalba Torrisi, Laura Zorzino, Giuseppe Viale, Elisabetta Pietri, Paolo Veronesi, Silvia Dellapasqua, Pier Francesco Ferrucci, Alberto Luini, Harriet Johansson, R. Ghisini, Aron Goldhirsch, Marco Colleoni	14
15	Serum EGFR and serum HER‐2/neu are useful predictive and prognostic markers in metastatic breast cancer patients treated with metronomic chemotherapy 2007 ·Cancer ·Maria Teresa Sandri, Harriet Johansson, Laura Zorzino, Michela Salvatici, Rita Passerini, Patrick Maisonneuve, Andrea Rocca, G. Peruzzotti, Marco Colleoni	32
16	Relationships between circulating hormone levels, mammographic percent density and breast cancer risk factors in postmenopausal women 2007 ·Breast Cancer Research and Treatment ·Harriet Johansson, Sara Gandini, Bernardo Bonanni, Frédérique Mariette, Aliana Guerrieri‐Gonzaga, Davide Serrano, Enrico Cassano, Francesca Ramazzotto, Laura Baglietto, Maria Teresa Sandri, Andrea DeCensi	56
17	Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis 2007 ·Breast Cancer Research and Treatment ·Debora Macis, Patrick Maisonneuve, Harriet Johansson, Bernardo Bonanni, Edoardo Botteri, Simona Iodice, B. Santillo, Silvana Penco, G Gucciardo, Giuseppe D’Aiuto, Marco Rosselli Del Turco, (unknown), Alberto Costa, Andrea DeCensi	54
18	Effects of low dose tamoxifen on circulating levels of hormones, C-telopeptide and HER2 extracellular domain in women with primary breast cancer 2006 ·Cancer Research ·Harriet Johansson, Massimiliano Cazzaniga, Bernardo Bonanni, Serena Mora, Frédérique Mariette, Giuseppe Pelosi, Ernst A. Lien, Chris Robertson, Andrea DeCensi	2
19	Serum levels of HER2 ECD can determine the response rate to low dose oral cyclophosphamide and methotrexate in patients with advanced stage breast carcinoma. 2004 ·PubMed ·Maria Teresa Sandri, Harriet Johansson, Marco Colleoni, Laura Zorzino, Rita Passerini, Laura Orlando, Giuseppe Viale	27
20	Effect of tamoxifen on lipoprotein(a) and insulin-like growth factor-I (IGF-I) in healthy women 1999 ·European Journal of Cancer ·Andrea DeCensi, C. Robertson, Bettina Ballardini, (unknown), Aliana Guerrieri‐Gonzaga, Bernardo Bonanni, (unknown), Harriet Johansson, A. Barreca, Donato Bettega, A. Costa	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact